九芝堂股份有限公司 关于对外投资的进展公告

Group 1 - The company has approved an external investment plan to acquire a 51.6667% stake in Harbin Jixianglong Biotechnology Co., Ltd. (Jixianglong) through a total investment of RMB 31 million [2][3] - The investment includes RMB 21 million for acquiring existing shares and RMB 10 million for subscribing to new registered capital, resulting in a total registered capital of RMB 1,135.55 million for Jixianglong [2] - Following the completion of the transaction, Jixianglong will become a subsidiary of the company and will be included in the consolidated financial statements [2][3] Group 2 - The company has successfully completed the necessary business registration changes and obtained the business license from the Harbin New Area Management Committee [3]